Association of RIP2 gene polymorphisms and systemic lupus erythematosus in a Chinese population

Mutagenesis

Volumn 27, Issue 3, 2012, Pages 319-322

  Li, Jing ^a,b   Tian, Jing ^a,b   Ma, Yan ^a,b   Cen, Han ^a,b   Leng, Rui Xue ^a,b   Lu, Man Man ^a,b   Chen, Gui Mei ^a,b   Feng, Chen Chen ^a,b   Tao, Jin Hui ^a,b,c   Pan, Hai Feng ^a,b   Ye, Dong Qing ^a,b  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b Anhui Provincial Laboratory of Population Health and Major Disease Screening and Diagnosis   (China)

^c ANHUI PROVINCIAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; RECEPTOR INTERACTING PROTEIN 2; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ALLELE; ARTICLE; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASE 2; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

EID: 84860210796     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/ger081     Document Type: Article

References (31)

1. Tikly, M. and Navarra, S. V. (2008) Lupus in the developing world-is it any different? Best Pract. Res. Clin. Rheumatol., 22, 643-655.
2. Wakeland, E. K., Liu, K., Graham, R. R. and Behrens, T. W. (2001) Delineating the genetic basis of systemic lupus erythematosus. Immunity, 15, 397-408.
3. Hess, E. V. (1995) Environmental lupus syndromes. Br. J. Rheumatol., 34, 597-599.
4. Huang, Z., Fu, B., Zheng, S. G., Li, X., Sun, R., Tian, Z. and Wei, H. (2011) Involvement of CD226p NK cells in immunopathogenesis of systemic lupus erythematosus. J. Immunol., 186, 3421-3431.
5. McCarthy, J. V., Ni, J. and Dixit, V. M. (1998) RIP2 is a novel NF-kappaBactivating and cell death-inducing kinase. J. Biol. Chem., 273, 16968-16975.
6. Inohara, N., del Peso, L., Koseki, T., Chen, S. and Núñez, G. (1998) RICK, a novel protein kinase containing a caspase recruitment domain, interacts with CLARP and regulates CD95-mediated apoptosis. J. Biol. Chem., 273, 12296-12300.
7. Thome, M., Hofmann, K., Burns, K., Martinon, F., Bodmer, J. L., Mattmann, C. and Tschopp, J. (1998) Identification of CARDIAK, a RIPlike kinase that associates with caspase-1. Curr. Biol., 8, 885-888.
8. Chin, A. I., Dempsey, P. W., Bruhn, K., Miller, J. F., Xu, Y. and Cheng, G. (2002) Involvement of receptor-interacting protein 2 in innate and adaptive immune responses. Nature, 416, 190-194.
9. Kobayashi, K., Inohara, N., Hernandez, L. D., Galán, J. E., Núñez, G., Janeway, C. A., Medzhitov, R. and Flavell, R. A. (2002) RICK/Rip2/ CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature, 416, 194-199.
10. Chin, A. I., Dempsey, P. W. and Cheng, G. (2005) Rip2: a key molecule that regulates both innate and acquired immunity. Curr. Med. Chem., 4, 35-42.
11. Abbott, D. W., Wilkins, A., Asara, J. M. and Cantley, L. C. (2004) The Crohn's disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO. Curr. Biol., 14, 2217-2227.
12. Negroni, A., Stronati, L., Pierdomenico, M., Tirindelli, D., Di Nardo, G., Mancini, V., Maiella, G. and Cucchiara, S. (2009) Activation of NOD2- mediated intestinal pathway in a pediatric population with Crohn's disease. Inflamm. Bowel Dis., 15, 1145-1154.
13. Tao, M., Scacheri, P. C., Marinis, J. M., Harhaj, E. W., Matesic, L. E. and Abbott, D. W. (2009) ITCH K63-ubiquitinates the NOD2 binding protein, RIP2, to influence inflammatory signaling pathways. Curr. Biol., 19, 1255-1263.
14. Shaw, P. J., Barr, M. J., Lukens, J. R., McGargill, M. A., Chi, H., Mak, T. W. and Kanneganti, T. D. (2011) Signaling via the RIP2 adaptor protein in central nervous system-infiltrating dendritic cells promotes inflammation and autoimmunity. Immunity, 34, 75-84.
15. Hochberg, M. C. (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum., 40, 1725.
16. Shi, Y. Y. and He, L. (2005) SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res., 15, 97-98.
17. Franchi, L., Park, J. H., Shaw, M. H., Marina-Garcia, N., Chen, G., Kim, Y. G. and Núñez, G. (2008) Intracellular NOD-like receptors in innate immunity, infection and disease. Cell Microbiol., 10, 1-8.
18. Becker, C. E. and O'Neill, L. A. (2007) Inflammasomes in inflammatory disorders: the role of TLRs and their interactions with NLRs. Semin. Immunopathol., 29, 239-248.
19. Fritz, J. H. and Girardin, S. E. (2005) How Toll-like receptors and Nod-like receptors contribute to innate immunity in mammals. J. Endotoxin Res., 11, 390-394.
20. Horton, C. G., Pan, Z. J. and Farris, A. D. (2010) Targeting Toll-like receptors for treatment of SLE. Mediators Inflamm. doi:10.1155/2010/ 498980.
21. Park, J. H., Kim, Y. G., McDonald, C., Kanneganti, T. D., Hasegawa, M., Body-Malapel, M., Inohara, N. and Núñez, G. (2007) RICK/RIP2 mediates innate immune responses induced through Nod1 and Nod2 but not TLRs. J. Immunol., 178, 2380-2386.
22. Hall, H. T., Wilhelm, M. T., Saibil, S. D., Mak, T. W., Flavell, R. A. and Ohashi, P. S. (2008) RIP2 contributes to Nod signaling but is not essential for T cell proliferation, T helper differentiation or TLR responses. Eur. J. Immunol., 38, 64-72.
23. Girardin, S. E., Travassos, L. H., Hervé, M., Blanot, D., Boneca, I. G., Philpott, D. J., Sansonetti, P. J. and Mengin-Lecreulx, D. (2003) Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2. J. Biol. Chem., 278, 41702-41708.
24. Pan, Q., Kravchenko, V., Katz, A. et al. (2006) NF-kappa B-inducing kinase regulates selected gene expression in the Nod2 signaling pathway. Infect. Immun., 74, 2121-2127.
25. Girardin, S. E., Tournebize, R., Mavris, M. et al. (2001) CARD4/Nod1 mediates NF-kappaB and JNK activation by invasive Shigella flexneri. EMBO Rep., 2, 736-742.
26. da Silva Correia, J., Miranda, Y., Leonard, N. and Ulevitch, R. (2007) SGT1 is essential for Nod1 activation. Proc. Natl Acad. Sci. U S A, 104, 6764-6769.
27. Hollenbach, E., Vieth, M. and Roessner, A. (2005) Inhibition of RIP2/ nuclear factor-kappaB and p38 signaling attenuates the infiammatory response in a murine model of Crohn disease. J. Biol. Chem., 280, 14981-14988.
28. Thiébaut, R., Douchin, V., Jung, C. et al. (2011) RIP2 polymorphisms in inflammatory bowel diseases. Inflamm. Bowel Dis., 17, 1055.
29. Nakashima, K., Hirota, T., Suzuki, Y. et al. (2006) Association of the RIP2 gene with childhood atopic asthma. Allergol. Int., 55, 77-83.
30. Zhang, F. R., Huang, W., Chen, S. M. et al. (2009) Genomewide association study of leprosy. N. Engl. J. Med., 361, 2609-2618.
31. Li, M., Zhou, Y., Feng, G. and Su, S. B. (2009) The critical role of Toll-like receptor signaling pathways in the induction and progression of autoimmune diseases. Curr. Mol. Med., 9, 365-374.